Where does Apogenix AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Apogenix AG ranks #10,542 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Apogenix AG hold?

Apogenix AG holds 29 US utility patents granted between 2015 and 2022, spanning 5 technology areas.

What is Apogenix AG's Innovation Score?

Apogenix AG has an Innovation Score of 29.6 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Apogenix AG focus on?

Apogenix AG's top technology area is C07K (Peptides) with 29 patents, ranking #328 of 3,615 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Apogenix AG's patent grant rate increasing or decreasing?

Apogenix AG's recent grant velocity is -47% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Apogenix AG's patents?

Apogenix AG's patents average 15.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Apogenix AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Apogenix AG

USPTO PatentsView assignee record - 29 granted patents across 5 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Apogenix ranks #10,542 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 5 technology areas.

#10,542
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.6/100): 15.8
avg claims per patent: -47%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10542 · Foreign Corporation #10,542 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,542/49,997
PHOTO-FINISH Amcor Flexibles…
CPC-NARROW C07K · 5 areas
INNOV-THIN 29.6/100
CLAIMS-RICH 15.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -47% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Amcor Flexibles North America, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Apogenix’s 29.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (40%) Velocity 0.5 pts (2%) Breadth 7.9 pts (27%) Claim depth 9.5 pts (32%)

Qualcomm Incorporated · highest

85
Goldpeak Innovantions · near

30
Apogenix · this assignee

30
CaptionCall · near

30
Encell Technology · near

30
Queen Mary &… · near

30
3D Lighting… · lowest

7

What this shows Apogenix's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Apogenix?

Each dot is one of Apogenix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apogenix’s own 15.8 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Apogenix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Apogenix's grants concentrate

Apogenix AG is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2015. By volume, Apogenix sits between Amcor Flexibles North America, Inc. and ATS Corporation.

Apogenix's three-year grant acceleration

Apogenix AG shows 1 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Amcor Flexibles N…

29
Ameriforge Group

29
Ametek

29
Aoyama Seisakusho

29
Arburg + KG

29
Archery Innovators

29
Asti Global Taiwan

29
ATS

29
Apogenix ◀

29

What this shows Apogenix holds 29 patents at rank #10,531, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Apogenix

By rank, the assignees closest to #10,531 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Apogenix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Apogenix, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Apogenix ranks #328 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (30 here).

CaptionCall, LLC 30 Encell Technology, Inc. 30 Queen Mary & Westfield College, University of London 30 Goldpeak Innovantions Inc. 30

Apogenix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Apogenix AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.4%
2016	6	20.7%
2017	3	10.3%
2018	4	13.8%
2019	5	17.2%
2020	7	24.1%
2021	2	6.9%
2022	1	3.4%

Which technologies does Apogenix AG patent most?

C07K - Peptides 29

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 27

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 21

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 19

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Apogenix AG's patent record in context - here's where to go next.

Apogenix AG's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #10,542 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Apogenix AG against Amcor Flexibles North America, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.